Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 30;130(8):498–508. doi: 10.1055/a-1608-0607

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

PMC Copyright notice

Fig. 5 — Intracellular ATP contributed to FAM3A-induced Akt activation and PDX1 upregulation. ( a ) The effect of CaM inhibitor (CPZ) on FAM3A-induced Akt-FOXO1 activation and PDX1 upregulation in HIT-T15 cells. The upper panel shows a representative image, and the lower panel shows a statistical graph. ( b ) Extended exposure to PPADS, suramin, and nifedipine for 24 h weakened FAM3A-induced Akt-FOXO1 phosphorylation and PDX1 upregulation. The upper panel shows a representative image and the lower panel shows a statistical graph. N=4–5, *P<0.05 vs. Ad-GFP, #P<0.05 vs. Ad-FAM3A.